Oppenheimer & Co’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18M | Buy |
122,998
+44,329
| +56% | +$6.84M | 0.22% | 84 |
|
|
2025
Q4 | $12.2M | Sell |
78,669
-69,664
| -47% | -$10.4M | 0.17% | 128 |
|
|
2025
Q3 | $20.6M | Buy |
148,333
+15,735
| +12% | +$2.13M | 0.25% | 72 |
|
|
2025
Q2 | $17.9M | Buy |
132,598
+37,841
| +40% | +$5.11M | 0.24% | 75 |
|
|
2025
Q1 | $13.8M | Buy |
94,757
+9,185
| +11% | +$1.33M | 0.21% | 99 |
|
|
2024
Q4 | $11.8M | Buy |
85,572
+7,458
| +10% | +$1.09M | 0.18% | 118 |
|
|
2024
Q3 | $12M | Sell |
78,114
-33,439
| -30% | -$5.07M | 0.18% | 109 |
|
|
2024
Q2 | $16.3M | Sell |
111,553
-16,332
| -13% | -$2.34M | 0.26% | 75 |
|
|
2024
Q1 | $18.9M | Buy |
127,885
+12,775
| +11% | +$1.83M | 0.31% | 60 |
|
|
2023
Q4 | $15.7M | Buy |
115,110
+5,608
| +5% | +$730K | 0.29% | 65 |
|
|
2023
Q3 | $14.1M | Buy |
109,502
+8,432
| +8% | +$1.12M | 0.29% | 70 |
|
|
2023
Q2 | $13.4M | Sell |
101,070
-12,068
| -11% | -$1.59M | 0.27% | 75 |
|
|
2023
Q1 | $14.6M | Buy |
113,138
+36,667
| +48% | +$4.79M | 0.31% | 64 |
|
|
2022
Q4 | $10.4M | Sell |
76,471
-14,777
| -16% | -$1.96M | 0.24% | 86 |
|
|
2022
Q3 | $11.1M | Buy |
91,248
+33,627
| +58% | +$4.33M | 0.26% | 78 |
|
|
2022
Q2 | $7.39M | Buy |
57,621
+18,237
| +46% | +$2.39M | 0.16% | 142 |
|
|
2022
Q1 | $5.39M | Sell |
39,384
-18,191
| -32% | -$2.41M | 0.1% | 257 |
|
|
2021
Q4 | $8.11M | Buy |
57,575
+21,399
| +59% | +$2.84M | 0.14% | 156 |
|
|
2021
Q3 | $4.61M | Sell |
36,176
-1,214
| -3% | -$160K | 0.09% | 272 |
|
|
2021
Q2 | $4.71M | Buy |
37,390
+9,472
| +34% | +$1.16M | 0.08% | 279 |
|
|
2021
Q1 | $3.26M | Sell |
27,918
-1,744
| -6% | -$201K | 0.07% | 345 |
|
|
2020
Q4 | $3.36M | Sell |
29,662
-18,429
| -38% | -$2.01M | 0.07% | 312 |
|
|
2020
Q3 | $5.07M | Sell |
48,091
-5,145
| -10% | -$542K | 0.13% | 174 |
|
|
2020
Q2 | $5.33M | Sell |
53,236
-162
| -0.3% | -$16K | 0.14% | 163 |
|
|
2020
Q1 | $4.73M | Buy |
53,398
+10,176
| +24% | +$989K | 0.14% | 152 |
|
|
2019
Q4 | $4.4M | Buy |
43,222
+11,773
| +37% | +$1.13M | 0.11% | 209 |
|
|
2019
Q3 | $2.83M | Buy |
31,449
+131
| +0.4% | +$12K | 0.08% | 300 |
|
|
2019
Q2 | $2.9M | Sell |
31,318
-8,898
| -22% | -$800K | 0.08% | 289 |
|
|
2019
Q1 | $3.69M | Sell |
40,216
-1,054
| -3% | -$95K | 0.1% | 234 |
|
|
2018
Q4 | $3.57M | Sell |
41,270
-1,940
| -4% | -$176K | 0.11% | 204 |
|
|
2018
Q3 | $4.11M | Buy |
43,210
+8,070
| +23% | +$729K | 0.1% | 212 |
|
|
2018
Q2 | $2.93M | Sell |
35,140
-889
| -2% | -$73.7K | 0.08% | 288 |
|
|
2018
Q1 | $2.93M | Sell |
36,029
-32
| -0.1% | -$2.73K | 0.08% | 299 |
|
|
2017
Q4 | $2.98M | Sell |
36,061
-4,100
| -10% | -$338K | 0.08% | 298 |
|
|
2017
Q3 | $3.28M | Sell |
40,161
-14,036
| -26% | -$1.13M | 0.09% | 273 |
|
|
2017
Q2 | $4.29M | Buy |
54,197
+3,675
| +7% | +$280K | 0.12% | 213 |
|
|
2017
Q1 | $3.76M | Buy |
50,522
+185
| +0.4% | +$13.5K | 0.11% | 237 |
|
|
2016
Q4 | $3.47M | Buy |
50,337
+27,003
| +116% | +$1.87M | 0.1% | 242 |
|
|
2016
Q3 | $1.68M | Sell |
23,334
-24,127
| -51% | -$1.78M | 0.05% | 422 |
|
|
2016
Q2 | $3.4M | Buy |
47,461
+32,033
| +208% | +$2.26M | 0.1% | 235 |
|
|
2016
Q1 | $1.05M | Sell |
15,428
-1,903
| -11% | -$127K | 0.03% | 530 |
|
|
2015
Q4 | $1.25M | Sell |
17,331
-1,040
| -6% | -$73.5K | 0.04% | 480 |
|
|
2015
Q3 | $1.22M | Sell |
18,371
-2,327
| -11% | -$170K | 0.04% | 510 |
|
|
2015
Q2 | $1.54M | Sell |
20,698
-3,306
| -14% | -$245K | 0.04% | 485 |
|
|
2015
Q1 | $1.74M | Buy |
24,004
+8,423
| +54% | +$601K | 0.05% | 451 |
|
|
2014
Q4 | $1.07M | Buy |
15,581
+1,690
| +12% | +$113K | 0.03% | 581 |
|
|
2014
Q3 | $888K | Sell |
13,891
-1,195
| -8% | -$74.8K | 0.03% | 639 |
|
|
2014
Q2 | $918K | Sell |
15,086
-2,042
| -12% | -$120K | 0.03% | 645 |
|
|
2014
Q1 | $1M | Buy |
17,128
+8,316
| +94% | +$479K | 0.03% | 601 |
|
|
2013
Q4 | $488K | Sell |
8,812
-1,559
| -15% | -$83.4K | 0.02% | 817 |
|
|
2013
Q3 | $524K | Sell |
10,371
-3,220
| -24% | -$162K | 0.02% | 747 |
|
|
2013
Q2 | $647K | Buy |
+13,591
| New | +$651K | 0.03% | 635 |
|
Other funds holding XLV
Oppenheimer & Co's XLV Position: Q1 2026 in Review
Oppenheimer & Co increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 56% in Q1 2026, buying an estimated $6.84M and bringing the position to 122,998 shares worth $18M. The position accounts for 0.22% of the portfolio, ranked #84.
Oppenheimer & Co first reported a position in XLV in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.6M in Q3 2025. 1,803 funds tracked by Wall St. Rank hold XLV as of Q1 2026.
- Oppenheimer & Co held 122,998 shares of State Street Health Care Select Sector SPDR ETF worth $18M as of Q1 2026.
- Oppenheimer & Co bought 44,329 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $6.84M.
- State Street Health Care Select Sector SPDR ETF made up 0.22% of Oppenheimer & Co's portfolio in Q1 2026, its #84 holding.
- Oppenheimer & Co first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's State Street Health Care Select Sector SPDR ETF position peaked at $20.6M in Q3 2025.
- 1,803 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.